Trial Profile
Elite sport and development of asthma: Airway inflammation and treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- 15 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Sep 2009 Planned number of patients changed from 40 to 18.
- 16 Sep 2009 Results were reported at the 19th Annual Congress of the European Respiratory Society.